TESTOSTERONE UNDECANOATE

TESTOSTERONE UNDECANOATE was reported 1958 times

TESTOSTERONE UNDECANOATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY OIL MICROEMBOLISM 84 0.7850
1 BLOOD GONADOTROPHIN ABNORMAL 1 0.3333
2 PULMONARY MICROEMBOLI 17 0.1683
3 CYSTADENOCARCINOMA OVARY 1 0.1667
4 MICROEMBOLISM 16 0.1404
5 BORDERLINE SEROUS TUMOUR OF OVARY 4 0.1290
6 CARBOHYDRATE DEFICIENT TRANSFERRIN INCREASED 1 0.1000
7 SEX HORMONE BINDING GLOBULIN DECREASED 3 0.1000
8 BILATERAL ORCHIDECTOMY 1 0.0909
9 FILARIASIS LYMPHATIC 1 0.0909
10 BLOOD TESTOSTERONE FREE INCREASED 5 0.0833
11 OVARIAN ENDOMETRIOID CARCINOMA 2 0.0476
12 OVARIAN GRANULOSA CELL TUMOUR 3 0.0400
13 INAPPROPRIATE SINUS TACHYCARDIA 1 0.0370
14 ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA 1 0.0357
15 PERFORMANCE ENHANCING PRODUCT USE 3 0.0303
16 DEHYDROEPIANDROSTERONE INCREASED 2 0.0290
17 VIRILISM 3 0.0273
18 HEPATIC NEUROENDOCRINE TUMOUR 1 0.0270
19 PHLEBOTOMY 2 0.0263
20 CEREBRAL ATAXIA 1 0.0227
21 BLOOD TESTOSTERONE ABNORMAL 23 0.0208
22 CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE 1 0.0182
23 BLOOD TESTOSTERONE INCREASED 38 0.0177
24 PNEUMONIA HAEMOPHILUS 8 0.0165
25 EXERTIONAL HEADACHE 1 0.0156
26 POLYCYTHAEMIA 32 0.0155
27 BLOOD TESTOSTERONE FREE DECREASED 2 0.0153
28 BORDERLINE OVARIAN TUMOUR 1 0.0149
29 HAEMATOCRIT INCREASED 34 0.0149
30 BLOOD TESTOSTERONE DECREASED 98 0.0143
31 HYPERGLOBULINAEMIA 1 0.0135
32 OESTRADIOL INCREASED 4 0.0133
33 ADMINISTRATION SITE ODOUR 1 0.0132
34 NODAL OSTEOARTHRITIS 4 0.0124
35 ARTERIAL CATHETERISATION 1 0.0122
36 ACNE CONGLOBATA 1 0.0122
37 SECONDARY HYPOGONADISM 4 0.0121
38 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 2 0.0114
39 INJECTION SITE DEFORMATION 1 0.0112
40 BLOOD LUTEINISING HORMONE DECREASED 2 0.0112
41 BACTERIAL PROSTATITIS 1 0.0101
42 EROSIVE DUODENITIS 8 0.0100
43 POST PROCEDURAL HYPOTHYROIDISM 2 0.0094
44 ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD 1 0.0091
45 CENTRAL SEROUS CHORIORETINOPATHY 6 0.0088
46 METAPLASIA 4 0.0085
47 FAT EMBOLISM 3 0.0085
48 TESTICULAR ATROPHY 7 0.0080
49 EPIPLOIC APPENDAGITIS 1 0.0078
50 AZOOSPERMIA 3 0.0078
51 CYSTIC FIBROSIS LUNG 1 0.0078
52 CYANOSIS CENTRAL 2 0.0077
53 AORTIC SURGERY 1 0.0076
54 ALLERGIC RESPIRATORY DISEASE 1 0.0072
55 FALLOPIAN TUBE CANCER 1 0.0069
56 CERVIX CARCINOMA STAGE IV 1 0.0069
57 BASOSQUAMOUS CARCINOMA 1 0.0067
58 CEREBRAL CONGESTION 1 0.0060
59 CEREBRAL VENOUS SINUS THROMBOSIS 5 0.0059
60 DECREASED VIBRATORY SENSE 2 0.0059
61 MUSCLE HYPERTROPHY 2 0.0057
62 LIBIDO DISORDER 7 0.0054
63 ACNE FULMINANS 1 0.0051
64 DEAFNESS PERMANENT 1 0.0051
65 HAEMOGLOBIN INCREASED 23 0.0050
66 BLOOD VISCOSITY INCREASED 3 0.0050
67 PROSTATIC PAIN 2 0.0049
68 SPONTANEOUS PENILE ERECTION 3 0.0048
69 INFERTILITY MALE 2 0.0044
70 SEXUALLY INAPPROPRIATE BEHAVIOUR 2 0.0043
71 PITUITARY TUMOUR BENIGN 7 0.0043
72 INJECTION SITE GRANULOMA 1 0.0042
73 ILLNESS ANXIETY DISORDER 1 0.0041
74 TRANSURETHRAL PROSTATECTOMY 2 0.0040
75 FOCAL NODULAR HYPERPLASIA 2 0.0038
76 TRANSVERSE SINUS THROMBOSIS 2 0.0038
77 CSF PRESSURE INCREASED 1 0.0038
78 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6 0.0037
79 HAEMOSIDEROSIS 1 0.0037
80 CHEMICAL BURNS OF EYE 1 0.0036
81 HYPERTENSIVE CARDIOMYOPATHY 1 0.0036
82 PERIPHERAL ARTERY THROMBOSIS 5 0.0036
83 ANDROGENETIC ALOPECIA 1 0.0035
84 INJECTION SITE CYST 1 0.0034
85 BLOOD OESTROGEN INCREASED 2 0.0034
86 BLOOD CREATINE DECREASED 1 0.0033
87 PROSTATE CANCER RECURRENT 2 0.0032
88 BORRELIA INFECTION 1 0.0032
89 IDIOPATHIC INTRACRANIAL HYPERTENSION 7 0.0031
90 HYPOTRICHOSIS 2 0.0031
91 BLOOD OSMOLARITY INCREASED 1 0.0030
92 RED BLOOD CELL COUNT INCREASED 8 0.0029
93 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
94 TREATMENT DELAYED 5 0.0029
95 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
96 INTRACRANIAL VENOUS SINUS THROMBOSIS 3 0.0028
97 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 1 0.0028
98 HEART VALVE STENOSIS 1 0.0028
99 IMMEDIATE POST-INJECTION REACTION 3 0.0027
100 SMALL FIBRE NEUROPATHY 2 0.0027
101 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
102 PROSTATOMEGALY 10 0.0025
103 TESTICULAR SWELLING 3 0.0024
104 GENITAL LESION 1 0.0024
105 GLIOSIS 1 0.0023
106 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
107 CARDIAC VENTRICULAR THROMBOSIS 3 0.0023
108 TONGUE PRURITUS 2 0.0023
109 HEART VALVE OPERATION 1 0.0023
110 CONGESTIVE HEPATOPATHY 1 0.0022
111 TESTICULAR PAIN 7 0.0022
112 HYPERTRICHOSIS 4 0.0022
113 PENILE SIZE REDUCED 2 0.0021
114 CARDIAC VALVE VEGETATION 1 0.0021
115 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
116 VASCULAR STENT THROMBOSIS 4 0.0020
117 BREAST CANCER MALE 1 0.0020
118 HEPATIC ADENOMA 1 0.0019
119 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 2 0.0019
120 URETEROLITHIASIS 2 0.0019
121 BONE CANCER METASTATIC 1 0.0019
122 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
123 ORCHITIS 2 0.0019
124 INVASIVE DUCTAL BREAST CARCINOMA 5 0.0018
125 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
126 BLOOD INSULIN INCREASED 1 0.0018
127 EJACULATION DELAYED 1 0.0018
128 HAEMORRHAGIC OVARIAN CYST 1 0.0017
129 PERIPHERAL EMBOLISM 2 0.0017
130 THERAPEUTIC PRODUCT EFFECT INCREASED 2 0.0017
131 ALLODYNIA 2 0.0017
132 HEPATITIS C VIRUS TEST POSITIVE 1 0.0017
133 DERMO-HYPODERMITIS 1 0.0017
134 ADRENAL ADENOMA 1 0.0017
135 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
136 SUSPECTED PRODUCT QUALITY ISSUE 3 0.0016
137 INJECTION SITE ABSCESS 4 0.0016
138 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
139 BLOOD CORTISOL DECREASED 1 0.0016
140 GLIOMA 1 0.0016
141 CALCIUM DEFICIENCY 2 0.0015
142 COUNTERFEIT PRODUCT ADMINISTERED 2 0.0015
143 FASCIITIS 1 0.0015
144 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
145 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
146 PRIAPISM 5 0.0014
147 DEPRESSIVE SYMPTOM 5 0.0014
148 RENAL INFARCT 2 0.0014
149 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
150 ATROPHIC VULVOVAGINITIS 1 0.0014
151 ARTERIAL INJURY 1 0.0013
152 BRONCHITIS BACTERIAL 1 0.0013
153 GINGIVAL HYPERTROPHY 2 0.0013
154 PROSTATITIS 4 0.0013
155 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
156 ORAL PRURITUS 3 0.0013
157 EXPOSURE VIA BODY FLUID 1 0.0013
158 SUSPECTED COUNTERFEIT PRODUCT 5 0.0013
159 URINE FLOW DECREASED 3 0.0013
160 HEMIANAESTHESIA 1 0.0013
161 IIIRD NERVE PARALYSIS 1 0.0012
162 ACNE PUSTULAR 1 0.0012
163 BALANOPOSTHITIS 1 0.0012
164 INJECTION RELATED REACTION 2 0.0012
165 PENIS DISORDER 3 0.0012
166 CSF PROTEIN INCREASED 1 0.0012
167 CAROTID ARTERY THROMBOSIS 1 0.0012
168 AORTIC VALVE INCOMPETENCE 5 0.0012
169 CORONARY ARTERY DISSECTION 1 0.0012
170 PRODUCT COUNTERFEIT 2 0.0012
171 ENDOCRINE OPHTHALMOPATHY 1 0.0012
172 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
173 DUODENAL ULCER 8 0.0011
174 DRUG LEVEL FLUCTUATING 1 0.0011
175 HYPERPLASIA 1 0.0011
176 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
177 ARTERIOVENOUS MALFORMATION 1 0.0011
178 SEBORRHOEA 4 0.0011
179 HAEMOCHROMATOSIS 1 0.0011
180 EXPOSURE VIA DIRECT CONTACT 1 0.0011
181 HEPATIC MASS 2 0.0010
182 COLON NEOPLASM 1 0.0010
183 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
184 CARDIAC ANEURYSM 1 0.0010
185 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
186 HAEMANGIOMA OF LIVER 1 0.0010
187 CORONARY ARTERY THROMBOSIS 2 0.0010
188 HYPOGONADISM 1 0.0010
189 DILATED CARDIOMYOPATHY 1 0.0010
190 LIBIDO INCREASED 2 0.0010
191 PENILE PAIN 3 0.0010
192 DYSLIPIDAEMIA 5 0.0010
193 EYE COLOUR CHANGE 1 0.0010
194 GENITAL HYPOAESTHESIA 1 0.0010
195 DIASTOLIC DYSFUNCTION 3 0.0010
196 BRUGADA SYNDROME 1 0.0010
197 VASCULAR OCCLUSION 2 0.0009
198 VENTRICULAR HYPOKINESIA 3 0.0009
199 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
200 CARDIAC HYPERTROPHY 1 0.0009
201 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
202 DRUG EFFECT VARIABLE 1 0.0009
203 PRODUCT AVAILABILITY ISSUE 20 0.0009
204 CORTISOL DECREASED 1 0.0009
205 EPIDIDYMITIS 1 0.0009
206 HORMONE-REFRACTORY PROSTATE CANCER 1 0.0008
207 URINARY HESITATION 2 0.0008
208 DIABETES INSIPIDUS 2 0.0008
209 CARDIAC DEATH 1 0.0008
210 HORMONE LEVEL ABNORMAL 4 0.0008
211 AMPUTATION 1 0.0008
212 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
213 AORTIC ANEURYSM 6 0.0008
214 HAEMORRHAGE URINARY TRACT 2 0.0008
215 LOSS OF LIBIDO 7 0.0008
216 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
217 HYPERSENSITIVITY VASCULITIS 2 0.0008
218 LARYNGOSPASM 2 0.0007
219 ERECTILE DYSFUNCTION 19 0.0007
220 PROSTATIC DISORDER 4 0.0007
221 HYPERPYREXIA 3 0.0007
222 AUDITORY DISORDER 1 0.0007
223 CHORIORETINOPATHY 1 0.0007
224 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
225 INJECTION SITE HYPOAESTHESIA 1 0.0007
226 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
227 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
228 DYSPNOEA AT REST 2 0.0007
229 INTENTIONAL UNDERDOSE 5 0.0007
230 BILIARY DILATATION 1 0.0007
231 DARK CIRCLES UNDER EYES 1 0.0007
232 BLINDNESS TRANSIENT 5 0.0007
233 BLOOD CREATINE INCREASED 3 0.0007
234 ENERGY INCREASED 4 0.0007
235 GENITAL PAIN 1 0.0007
236 INFERTILITY 1 0.0007
237 EPICONDYLITIS 1 0.0007
238 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
239 PROSTATIC SPECIFIC ANTIGEN INCREASED 9 0.0007
240 CALCULUS URINARY 1 0.0006
241 FOREIGN BODY IN THROAT 2 0.0006
242 POLYMYALGIA RHEUMATICA 2 0.0006
243 PORTAL VEIN THROMBOSIS 2 0.0006
244 ANGINA UNSTABLE 4 0.0006
245 BREAST ENLARGEMENT 2 0.0006
246 INJECTION SITE INFECTION 2 0.0006
247 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
248 BLOOD CALCIUM ABNORMAL 1 0.0006
249 ANXIETY DISORDER 2 0.0006
250 POTENTIATING DRUG INTERACTION 2 0.0006
251 FOOD AVERSION 1 0.0006
252 GLIOBLASTOMA 1 0.0006
253 PRODUCT COLOUR ISSUE 3 0.0006
254 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
255 TACHYPHRENIA 2 0.0006
256 MICTURITION DISORDER 2 0.0006
257 HYPOPITUITARISM 1 0.0006
258 EMOTIONAL POVERTY 1 0.0006
259 FACIAL PARESIS 2 0.0006
260 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
261 CARDIAC ABLATION 1 0.0006
262 PARAESTHESIA ORAL 8 0.0006
263 CAROTID ARTERY OCCLUSION 2 0.0005
264 COUGH 153 0.0005
265 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
266 INTRACRANIAL PRESSURE INCREASED 3 0.0005
267 INJECTION SITE CELLULITIS 1 0.0005
268 THROAT CLEARING 2 0.0005
269 IMPATIENCE 1 0.0005
270 INTERVERTEBRAL DISCITIS 1 0.0005
271 HYPERCOAGULATION 1 0.0005
272 INSURANCE ISSUE 8 0.0005
273 DRUG EFFECT DECREASED 28 0.0005
274 RHEUMATOID FACTOR POSITIVE 3 0.0005
275 TESTIS CANCER 2 0.0005
276 COLD SWEAT 9 0.0005
277 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
278 HYPERAEMIA 1 0.0005
279 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 36 0.0005
280 GENE MUTATION 1 0.0005
281 TRICUSPID VALVE INCOMPETENCE 4 0.0005
282 BLOOD DISORDER 4 0.0005
283 EJACULATION FAILURE 1 0.0005
284 HYPOPHYSITIS 1 0.0005
285 CARDIAC DISCOMFORT 1 0.0005
286 PRODUCT PHYSICAL ISSUE 10 0.0005
287 INJECTION SITE NECROSIS 1 0.0005
288 PERIPHERAL ISCHAEMIA 2 0.0005
289 CAPILLARY LEAK SYNDROME 1 0.0005
290 CHEST INJURY 1 0.0005
291 EMBOLISM 4 0.0005
292 VITAMIN D DECREASED 4 0.0005
293 TENSION HEADACHE 2 0.0005
294 HYPERPHOSPHATAEMIA 1 0.0005
295 FAECES DISCOLOURED 10 0.0005
296 GASTRIC BYPASS 1 0.0005
297 BIPOLAR I DISORDER 1 0.0005
298 GROIN PAIN 4 0.0005
299 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
300 PULMONARY CONGESTION 6 0.0005
301 PHYSICAL DISABILITY 2 0.0005
302 CHOLESTATIC LIVER INJURY 1 0.0004
303 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
304 URINARY TRACT DISORDER 2 0.0004
305 PAPILLOEDEMA 2 0.0004
306 HAIR GROWTH ABNORMAL 3 0.0004
307 RIGHT VENTRICULAR FAILURE 3 0.0004
308 BLOOD TEST ABNORMAL 6 0.0004
309 BLOOD PROLACTIN INCREASED 2 0.0004
310 PRODUCT SUPPLY ISSUE 3 0.0004
311 SLEEP APNOEA SYNDROME 8 0.0004
312 MAJOR DEPRESSION 3 0.0004
313 MOOD SWINGS 13 0.0004
314 DERMAL CYST 1 0.0004
315 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
316 HYPERVOLAEMIA 2 0.0004
317 HYPERPARATHYROIDISM SECONDARY 1 0.0004
318 PRODUCT ADMINISTRATION ERROR 8 0.0004
319 BRAIN ABSCESS 1 0.0004
320 MUSCLE ATROPHY 5 0.0004
321 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
322 SLUGGISHNESS 4 0.0004
323 CANCER PAIN 1 0.0004
324 HYPERHIDROSIS 50 0.0004
325 BLOOD CHLORIDE DECREASED 1 0.0004
326 PRODUCT ODOUR ABNORMAL 4 0.0004
327 ABDOMINAL MASS 1 0.0004
328 BREAST SWELLING 1 0.0004
329 FRUSTRATION TOLERANCE DECREASED 3 0.0004
330 HYPOCALCAEMIA 7 0.0004
331 SUBSTANCE ABUSE 3 0.0004
332 ANORGASMIA 1 0.0004
333 PALLOR 10 0.0004
334 THERAPY INTERRUPTED 26 0.0004
335 DEAFNESS UNILATERAL 2 0.0004
336 CHOKING SENSATION 2 0.0004
337 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
338 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
339 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
340 ELECTRIC SHOCK SENSATION 1 0.0004
341 PRODUCT LEAKAGE 2 0.0004
342 SENSATION OF FOREIGN BODY 3 0.0004
343 EJACULATION DISORDER 1 0.0004
344 BRONCHOSPASM 5 0.0004
345 NEUROLOGICAL SYMPTOM 2 0.0003
346 DRUG ABUSE 29 0.0003
347 BILIARY COLIC 1 0.0003
348 DEVICE POWER SOURCE ISSUE 1 0.0003
349 URINE ODOUR ABNORMAL 2 0.0003
350 CREPITATIONS 1 0.0003
351 CARDIAC PACEMAKER INSERTION 2 0.0003
352 POLYNEUROPATHY 4 0.0003
353 THROAT TIGHTNESS 9 0.0003
354 OROPHARYNGEAL DISCOMFORT 3 0.0003
355 INGUINAL HERNIA 2 0.0003
356 DYSAESTHESIA 1 0.0003
357 ANAPHYLACTIC REACTION 18 0.0003
358 LARYNGEAL OEDEMA 2 0.0003
359 INJECTION SITE HYPERSENSITIVITY 1 0.0003
360 PHOTOPSIA 2 0.0003
361 BILE DUCT STONE 1 0.0003
362 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
363 ANAPHYLACTIC SHOCK 8 0.0003
364 FACET JOINT SYNDROME 1 0.0003
365 HEPATIC NEOPLASM 1 0.0003
366 BRADYPHRENIA 2 0.0003
367 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
368 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
369 PRODUCT TASTE ABNORMAL 4 0.0003
370 CHEST DISCOMFORT 30 0.0003
371 INFARCTION 2 0.0003
372 EYE MOVEMENT DISORDER 2 0.0003
373 HEPATIC FIBROSIS 1 0.0003
374 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
375 ACNE 22 0.0003
376 DEPRESSION SUICIDAL 1 0.0003
377 ORAL DISCOMFORT 4 0.0003
378 AORTIC STENOSIS 1 0.0003
379 INJECTION SITE DISCOMFORT 3 0.0003
380 EMBOLIC STROKE 1 0.0003
381 FIBRIN D DIMER INCREASED 1 0.0003
382 CONJUNCTIVAL HYPERAEMIA 1 0.0003
383 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
384 METASTASIS 2 0.0003
385 DECREASED ACTIVITY 3 0.0003
386 CARDIOVASCULAR DISORDER 7 0.0003
387 INJECTION SITE HAEMATOMA 4 0.0003
388 HYPOMANIA 1 0.0003
389 AMYLASE INCREASED 1 0.0003
390 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
391 THROAT IRRITATION 12 0.0003
392 MITRAL VALVE INCOMPETENCE 3 0.0003
393 HEPATOCELLULAR CARCINOMA 2 0.0003
394 PROTEINURIA 5 0.0003
395 FEELING JITTERY 5 0.0003
396 CLAVICLE FRACTURE 1 0.0003
397 GINGIVAL DISORDER 1 0.0003
398 CONCUSSION 2 0.0003
399 APNOEA 2 0.0003
400 CHOKING 5 0.0003
401 CERVIX CARCINOMA 1 0.0003
402 SEXUAL DYSFUNCTION 3 0.0003
403 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 46 0.0003
404 CYANOSIS 4 0.0003
405 HYPERPHAGIA 1 0.0003
406 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
407 FUNGAL SKIN INFECTION 1 0.0002
408 BLOOD POTASSIUM INCREASED 4 0.0002
409 POLYURIA 2 0.0002
410 ARTHRITIS BACTERIAL 1 0.0002
411 HYPERURICAEMIA 1 0.0002
412 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
413 CYST 3 0.0002
414 CONGESTIVE CARDIOMYOPATHY 1 0.0002
415 ERECTION INCREASED 1 0.0002
416 ACUTE MYOCARDIAL INFARCTION 7 0.0002
417 LABORATORY TEST ABNORMAL 7 0.0002
418 BUNDLE BRANCH BLOCK LEFT 1 0.0002
419 INJECTION SITE IRRITATION 3 0.0002
420 CARDIAC FAILURE CHRONIC 1 0.0002
421 HEPATIC PAIN 1 0.0002
422 SCAR 4 0.0002
423 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
424 PRODUCT CONTAINER ISSUE 2 0.0002
425 ABNORMAL SENSATION IN EYE 1 0.0002
426 INJECTION SITE INDURATION 3 0.0002
427 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
428 NODULE 3 0.0002
429 GYNAECOMASTIA 7 0.0002
430 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
431 RESPIRATORY RATE INCREASED 2 0.0002
432 ANAL INCONTINENCE 2 0.0002
433 DRUG EFFECT DELAYED 1 0.0002
434 MOOD ALTERED 6 0.0002
435 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
436 PATHOGEN RESISTANCE 2 0.0002
437 PERIPHERAL COLDNESS 3 0.0002
438 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
439 FEELING COLD 6 0.0002
440 DYSGEUSIA 16 0.0002
441 PERSONALITY CHANGE 2 0.0002
442 FEELING OF DESPAIR 1 0.0002
443 VERTIGO 13 0.0002
444 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
445 CARDIAC TAMPONADE 1 0.0002
446 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
447 INCREASED APPETITE 4 0.0002
448 BLOOD PRESSURE INCREASED 32 0.0002
449 FAECAL INCONTINENCE 1 0.0002
450 AFFECT LABILITY 2 0.0002
451 MENTAL DISORDER 9 0.0002
452 DRUG INEFFECTIVE 271 0.0002
453 AUTOIMMUNE DISORDER 2 0.0002
454 VITAMIN D DEFICIENCY 2 0.0002
455 INFLAMMATORY BOWEL DISEASE 2 0.0002
456 BODY TEMPERATURE DECREASED 2 0.0002
457 COLON CANCER 3 0.0002
458 INJECTION SITE INFLAMMATION 1 0.0002
459 HYPERNATRAEMIA 1 0.0002
460 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
461 HYPERAMMONAEMIA 1 0.0002
462 SALIVARY HYPERSECRETION 2 0.0002
463 BURNING SENSATION 14 0.0002
464 BRAIN INJURY 2 0.0002
465 HOT FLUSH 15 0.0002
466 CORONARY ARTERY STENOSIS 1 0.0002
467 DYSPNOEA 112 0.0002
468 LYMPHADENOPATHY 7 0.0002
469 DYSPHORIA 1 0.0002
470 FEELING HOT 12 0.0002
471 ENDOCARDITIS 1 0.0002
472 CACHEXIA 1 0.0002
473 OFF LABEL USE 170 0.0002
474 LYMPHOMA 3 0.0002
475 APLASTIC ANAEMIA 1 0.0002
476 WEIGHT FLUCTUATION 2 0.0002
477 SYNCOPE 19 0.0002
478 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
479 DEPRESSED MOOD 10 0.0002
480 RENAL PAIN 2 0.0002
481 ANORECTAL DISCOMFORT 1 0.0002
482 RETCHING 4 0.0002
483 BREAST PAIN 2 0.0002
484 HEREDITARY ANGIOEDEMA 2 0.0002
485 NIGHT SWEATS 6 0.0002
486 INJECTION SITE DISCHARGE 1 0.0002
487 JAUNDICE 5 0.0002
488 ANAL ABSCESS 1 0.0002
489 DISTURBANCE IN ATTENTION 10 0.0002
490 ATRIAL FIBRILLATION 18 0.0002
491 CHEILITIS 1 0.0002
492 ERYTHEMA OF EYELID 1 0.0002
493 PARAESTHESIA 29 0.0002
494 BIPOLAR DISORDER 2 0.0002
495 CHEST PAIN 34 0.0002
496 TREATMENT NONCOMPLIANCE 10 0.0002
497 INJECTION SITE NODULE 2 0.0002
498 INTESTINAL ISCHAEMIA 1 0.0002
499 AGGRESSION 9 0.0002
500 URINARY RETENTION 6 0.0002
501 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
502 HYPERTENSIVE CRISIS 2 0.0002
503 HEART RATE ABNORMAL 1 0.0002
504 INJECTION SITE PAIN 55 0.0002
505 CHOLECYSTITIS ACUTE 1 0.0002
506 CIRCULATORY COLLAPSE 3 0.0002
507 GENERALISED ERYTHEMA 1 0.0002
508 ANGINA PECTORIS 5 0.0002
509 MYOCARDITIS 2 0.0002
510 HERPES VIRUS INFECTION 1 0.0002
511 BLOOD URIC ACID INCREASED 1 0.0002
512 EYELID OEDEMA 2 0.0002
513 UNEVALUABLE EVENT 13 0.0002
514 POST PROCEDURAL HAEMORRHAGE 2 0.0002
515 EOSINOPHILIA 3 0.0002
516 SURGERY 10 0.0002
517 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
518 HEAD DISCOMFORT 3 0.0002
519 BRADYKINESIA 1 0.0002
520 ISCHAEMIC STROKE 3 0.0002
521 PRODUCT PRESCRIBING ERROR 4 0.0002
522 CHOLECYSTITIS 2 0.0002
523 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
524 MUSCLE RIGIDITY 2 0.0002
525 IRRITABILITY 10 0.0002
526 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
527 MENTAL IMPAIRMENT 4 0.0002
528 ILL-DEFINED DISORDER 10 0.0002
529 SCHIZOPHRENIA 2 0.0002
530 PRESYNCOPE 4 0.0002
531 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
532 DYSURIA 6 0.0002
533 DYSPEPSIA 16 0.0002
534 CARDIOMEGALY 2 0.0002
535 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
536 TENDON RUPTURE 2 0.0002
537 DRUG DIVERSION 1 0.0002
538 GENERALISED OEDEMA 2 0.0002
539 MIDDLE INSOMNIA 3 0.0002
540 ASTHENIA 60 0.0002
541 DRUG-INDUCED LIVER INJURY 5 0.0002
542 HEAD INJURY 5 0.0002
543 FOREIGN BODY SENSATION IN EYES 1 0.0002
544 DRUG PRESCRIBING ERROR 3 0.0002
545 THERAPY CESSATION 8 0.0002
546 HAEMOGLOBIN ABNORMAL 1 0.0002
547 PRESCRIBED OVERDOSE 3 0.0002
548 CARDIAC FLUTTER 1 0.0002
549 BREAST CANCER STAGE III 1 0.0002
550 EAR PAIN 3 0.0002
551 HYPERPROLACTINAEMIA 1 0.0002
552 DIPLOPIA 4 0.0002
553 TINNITUS 7 0.0002
554 INCORRECT PRODUCT STORAGE 2 0.0002
555 IMMUNE SYSTEM DISORDER 2 0.0002
556 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
557 BLOOD PRESSURE ABNORMAL 3 0.0002
558 APPETITE DISORDER 1 0.0002
559 CARDIAC FAILURE ACUTE 1 0.0001
560 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
561 CHOLECYSTITIS CHRONIC 1 0.0001
562 BREAST MASS 1 0.0001
563 INTENTIONAL PRODUCT MISUSE 13 0.0001
564 BRONCHIECTASIS 1 0.0001
565 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
566 ABNORMAL LOSS OF WEIGHT 1 0.0001
567 GINGIVAL BLEEDING 2 0.0001
568 INJECTION SITE WARMTH 3 0.0001
569 PALPITATIONS 17 0.0001
570 RHABDOMYOLYSIS 6 0.0001
571 HYPERTRANSAMINASAEMIA 1 0.0001
572 FORMICATION 1 0.0001
573 HUNGER 2 0.0001
574 WITHDRAWAL SYNDROME 6 0.0001
575 SKIN REACTION 2 0.0001
576 LIVER FUNCTION TEST INCREASED 3 0.0001
577 IMPAIRED QUALITY OF LIFE 2 0.0001
578 DEEP VEIN THROMBOSIS 9 0.0001
579 FAECES SOFT 1 0.0001
580 PROSTATE CANCER 11 0.0001
581 HYPOPHOSPHATAEMIA 1 0.0001
582 CEREBRAL DISORDER 1 0.0001
583 ARTHROPOD BITE 1 0.0001
584 HEPATOTOXICITY 3 0.0001
585 RESPIRATORY DISORDER 4 0.0001
586 FEELING ABNORMAL 32 0.0001
587 LOSS OF CONSCIOUSNESS 17 0.0001
588 APHASIA 4 0.0001
589 HEART RATE INCREASED 13 0.0001
590 HYPERTHERMIA 1 0.0001
591 EPILEPSY 4 0.0001
592 HIP ARTHROPLASTY 2 0.0001
593 DISSOCIATION 1 0.0001
594 PERICARDIAL EFFUSION 3 0.0001
595 HAEMORRHAGIC STROKE 1 0.0001
596 FLUSHING 13 0.0001
597 PRODUCT USE COMPLAINT 2 0.0001
598 DRUG SCREEN POSITIVE 1 0.0001
599 RESPIRATORY TRACT CONGESTION 2 0.0001
600 HALLUCINATION, AUDITORY 2 0.0001
601 GINGIVAL PAIN 1 0.0001
602 OBESITY 2 0.0001
603 SCIATICA 2 0.0001
604 BLOOD PRESSURE FLUCTUATION 3 0.0001
605 SENSORY DISTURBANCE 2 0.0001
606 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
607 BACK DISORDER 2 0.0001
608 CEREBRAL INFARCTION 3 0.0001
609 HYPERTENSION 26 0.0001
610 PRODUCT DOSE OMISSION 8 0.0001
611 DIZZINESS 61 0.0001
612 LIVER INJURY 3 0.0001
613 METASTASES TO BONE 2 0.0001
614 BRONCHITIS 9 0.0001
615 OSTEOPOROSIS 5 0.0001
616 SEIZURE 14 0.0001
617 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
618 ACUTE CORONARY SYNDROME 1 0.0001
619 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
620 ROAD TRAFFIC ACCIDENT 5 0.0001
621 CELLULITIS 6 0.0001
622 DRUG USE DISORDER 1 0.0001
623 HYPERSENSITIVITY 22 0.0001
624 GASTRIC CANCER 3 0.0001
625 ANGER 4 0.0001
626 HEMIPARESIS 2 0.0001
627 INJECTION SITE SWELLING 9 0.0001
628 HAEMATOMA 3 0.0001
629 MULTI-ORGAN FAILURE 2 0.0001
630 ASTHMA 13 0.0001
631 ORTHOSTATIC HYPOTENSION 2 0.0001
632 ANHEDONIA 3 0.0001
633 HEART RATE DECREASED 4 0.0001
634 CARDIOTOXICITY 1 0.0001
635 CEREBRAL HAEMORRHAGE 4 0.0001
636 MALAISE 49 0.0001
637 FEAR 3 0.0001
638 GOUT 2 0.0001
639 HEAVY MENSTRUAL BLEEDING 1 0.0001
640 TOOTHACHE 2 0.0001
641 RESTLESSNESS 4 0.0001
642 SUICIDAL IDEATION 10 0.0001
643 NEPHROLITHIASIS 5 0.0001
644 BRAIN NEOPLASM 1 0.0001
645 RESPIRATORY DISTRESS 3 0.0001
646 HEPATIC STEATOSIS 2 0.0001
647 THINKING ABNORMAL 2 0.0001
648 ERYTHEMA MULTIFORME 1 0.0001
649 DEFORMITY 1 0.0001
650 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
651 EYE PAIN 6 0.0001
652 ARRHYTHMIA 5 0.0001
653 INTENTIONAL DOSE OMISSION 3 0.0001
654 PRODUCTIVE COUGH 5 0.0001
655 LETHARGY 6 0.0001
656 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
657 LOWER LIMB FRACTURE 2 0.0001
658 ERUCTATION 2 0.0001
659 DIZZINESS POSTURAL 1 0.0001
660 DYSTONIA 2 0.0001
661 HYPOGLYCAEMIA 5 0.0001
662 PRODUCT QUALITY ISSUE 14 0.0001
663 DYSPHONIA 6 0.0001
664 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
665 COELIAC DISEASE 1 0.0001
666 HEPATOMEGALY 1 0.0001
667 FATIGUE 79 0.0001
668 WHEEZING 6 0.0001
669 HYPOTONIA 1 0.0001
670 SPINAL FRACTURE 2 0.0001
671 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
672 INTENTIONAL SELF-INJURY 2 0.0001
673 BODY TEMPERATURE INCREASED 2 0.0001
674 INJECTION SITE RASH 3 0.0001
675 EAR DISCOMFORT 1 0.0001
676 EMOTIONAL DISORDER 3 0.0001
677 HELICOBACTER INFECTION 1 0.0001
678 ERYTHEMA 20 0.0001
679 RIB FRACTURE 2 0.0001
680 DEPRESSION 22 0.0001
681 PULMONARY HYPERTENSION 2 0.0001
682 UNDERDOSE 7 0.0001
683 MUSCULOSKELETAL PAIN 5 0.0001
684 FOLLICULITIS 1 0.0001
685 AGITATION 7 0.0001
686 KNEE ARTHROPLASTY 2 0.0001
687 MOUTH ULCERATION 2 0.0001
688 HALLUCINATION, VISUAL 2 0.0001
689 PULMONARY EMBOLISM 9 0.0001
690 IRRITABLE BOWEL SYNDROME 2 0.0001
691 BREAST CANCER METASTATIC 1 0.0001
692 POOR QUALITY SLEEP 2 0.0001
693 SWELLING FACE 6 0.0001
694 CHRONIC KIDNEY DISEASE 7 0.0001
695 PRODUCT PRESCRIBING ISSUE 2 0.0001
696 PAIN IN EXTREMITY 27 0.0001
697 DENTAL CARIES 1 0.0001
698 BLOOD PRESSURE DECREASED 6 0.0001
699 FOOT DEFORMITY 1 0.0001
700 LIP SWELLING 3 0.0001
701 MEDICATION ERROR 5 0.0001
702 WEIGHT DECREASED 25 0.0001
703 EYE PRURITUS 3 0.0001
704 TYPE 2 DIABETES MELLITUS 3 0.0001
705 THERAPY NON-RESPONDER 4 0.0001
706 PANCREATITIS ACUTE 2 0.0001
707 CHROMATURIA 2 0.0001
708 MUSCULAR WEAKNESS 10 0.0001
709 ANXIETY 25 0.0001
710 HAEMATURIA 3 0.0001
711 CHOLECYSTECTOMY 1 0.0001
712 THROMBOSIS 7 0.0001
713 ELECTROLYTE IMBALANCE 1 0.0001
714 RASH MACULAR 3 0.0001
715 SWELLING 8 0.0001
716 PRODUCT DOSE OMISSION ISSUE 25 0.0001
717 PERIPHERAL SWELLING 13 0.0001
718 ATAXIA 1 0.0001
719 CATARACT 5 0.0001
720 ACCIDENT 1 0.0001
721 DIABETIC KETOACIDOSIS 2 0.0001
722 HEPATITIS C 1 0.0001
723 BURSITIS 1 0.0001
724 ADRENAL INSUFFICIENCY 1 0.0001
725 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
726 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
727 INJECTION SITE MASS 3 0.0001
728 HYPERCALCAEMIA 1 0.0001
729 ABASIA 2 0.0001
730 HEPATIC FUNCTION ABNORMAL 3 0.0001
731 WEIGHT INCREASED 18 0.0001
732 MYOCARDIAL INFARCTION 14 0.0001
733 VISION BLURRED 11 0.0001
734 HEADACHE 50 0.0001
735 ABDOMINAL PAIN LOWER 2 0.0001
736 PRODUCT COMPLAINT 2 0.0001
737 TACHYCARDIA 7 0.0001
738 BACK PAIN 18 0.0001
739 HIATUS HERNIA 1 0.0001
740 CHILLS 9 0.0001
741 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
742 BLOOD CREATININE INCREASED 5 0.0001
743 NERVOUSNESS 4 0.0001
744 ALOPECIA 15 0.0001
745 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
746 PANCREATITIS 4 0.0001
747 EAR INFECTION 2 0.0001
748 JOINT SWELLING 9 0.0001
749 COVID-19 13 0.0001
750 FREQUENT BOWEL MOVEMENTS 2 0.0001
751 OEDEMA PERIPHERAL 9 0.0001
752 HEPATIC ENZYME INCREASED 5 0.0001
753 MIGRAINE 7 0.0001
754 LUNG NEOPLASM MALIGNANT 3 0.0001
755 CORONARY ARTERY OCCLUSION 1 0.0001
756 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
757 RESPIRATORY ARREST 2 0.0001
758 ABNORMAL DREAMS 2 0.0001
759 HAEMOPTYSIS 2 0.0001
760 COORDINATION ABNORMAL 1 0.0001
761 RENAL IMPAIRMENT 6 0.0001
762 CARPAL TUNNEL SYNDROME 1 0.0001
763 OXYGEN SATURATION DECREASED 4 0.0001
764 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
765 SLEEP DISORDER 5 0.0001
766 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
767 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
768 RECTAL HAEMORRHAGE 3 0.0001
769 HYPERSOMNIA 2 0.0001
770 CARDIOGENIC SHOCK 1 0.0001
771 MOBILITY DECREASED 5 0.0001
772 PRODUCT SUBSTITUTION ISSUE 4 0.0001
773 DRUG INTERACTION 11 0.0001
774 PANCREATIC CARCINOMA 2 0.0001
775 PRODUCT USE ISSUE 13 0.0001
776 HYPERTHYROIDISM 1 0.0001
777 ABDOMINAL PAIN 16 0.0001
778 APATHY 1 0.0001
779 GASTROENTERITIS 1 0.0001
780 SINUSITIS 7 0.0001
781 NASAL CONGESTION 4 0.0001
782 ASCITES 2 0.0001
783 PSYCHOTIC DISORDER 2 0.0001
784 CARDIOMYOPATHY 1 0.0001
785 URINARY INCONTINENCE 2 0.0001
786 RENAL INJURY 2 0.0001
787 PULMONARY OEDEMA 3 0.0001
788 GASTROINTESTINAL DISORDER 6 0.0001
789 HAEMORRHAGE INTRACRANIAL 1 0.0001
790 HYPOAESTHESIA 10 0.0001
791 BONE LOSS 1 0.0001
792 HYPOAESTHESIA ORAL 1 0.0001
793 CORONARY ARTERY DISEASE 2 0.0001
794 ECONOMIC PROBLEM 1 0.0001
795 BLOOD COUNT ABNORMAL 1 0.0001
796 PLEURAL EFFUSION 4 0.0001
797 SKIN DISCOLOURATION 3 0.0001
798 DEVICE RELATED INFECTION 1 0.0001
799 LIMB DISCOMFORT 2 0.0001
800 BLOOD CHOLESTEROL INCREASED 3 0.0001
801 EJECTION FRACTION DECREASED 1 0.0001
802 ACUTE MYELOID LEUKAEMIA 1 0.0001
803 CARDIAC DISORDER 6 0.0001
804 BASAL CELL CARCINOMA 1 0.0001
805 NERVOUS SYSTEM DISORDER 2 0.0001
806 SWOLLEN TONGUE 2 0.0001
807 BRAIN FOG 1 0.0001
808 PYREXIA 22 0.0001
809 OCULAR HYPERAEMIA 3 0.0001
810 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
811 NEUROPATHY PERIPHERAL 6 0.0001
812 INTENTIONAL OVERDOSE 4 0.0001
813 CHOLELITHIASIS 2 0.0001
814 OSTEONECROSIS 2 0.0001
815 EYE DISORDER 2 0.0001
816 CARDIAC ARREST 5 0.0001
817 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
818 TREMOR 10 0.0001
819 VISUAL ACUITY REDUCED 2 0.0001
820 VIRAL INFECTION 2 0.0001
821 SKIN DISORDER 2 0.0001
822 NEOPLASM MALIGNANT 4 0.0001
823 PRURITUS 23 0.0001
824 GAIT INABILITY 2 0.0001
825 HYPOTENSION 12 0.0001
826 BLOOD UREA INCREASED 1 0.0001
827 ABDOMINAL DISCOMFORT 10 0.0001
828 CEREBROVASCULAR ACCIDENT 10 0.0001
829 FLUID RETENTION 3 0.0001
830 INFLAMMATION 3 0.0001
831 NIGHTMARE 2 0.0001
832 DEVICE DEFECTIVE 1 0.0001
833 DEVICE USE ISSUE 1 0.0001
834 INJURY 4 0.0001
835 HYPOXIA 2 0.0001
836 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
837 INJECTION SITE ERYTHEMA 7 0.0001
838 INSOMNIA 15 0.0001
839 PLATELET COUNT DECREASED 6 0.0001
840 ADVERSE DRUG REACTION 5 0.0001
841 INFECTION 8 0.0001
842 CRYING 2 0.0001
843 HYPERGLYCAEMIA 2 0.0001
844 PANIC ATTACK 2 0.0001
845 END STAGE RENAL DISEASE 1 0.0001
846 ACCIDENTAL OVERDOSE 2 0.0001
847 SOMNOLENCE 11 0.0001
848 BLOOD GLUCOSE ABNORMAL 1 0.0001
849 OROPHARYNGEAL PAIN 5 0.0001
850 ARTHROPATHY 3 0.0001
851 CONJUNCTIVITIS 1 0.0001
852 PAIN 33 0.0001
853 NECK PAIN 3 0.0001
854 DYSPNOEA EXERTIONAL 2 0.0001
855 ARTHRALGIA 22 0.0001
856 DYSPHAGIA 5 0.0001
857 ACUTE RESPIRATORY FAILURE 1 0.0001
858 GLAUCOMA 1 0.0001
859 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
860 HAEMORRHOIDS 1 0.0001
861 DISABILITY 1 0.0001
862 CARDIAC FAILURE 4 0.0000
863 EMOTIONAL DISTRESS 6 0.0000
864 SUICIDE ATTEMPT 3 0.0000
865 BONE MARROW FAILURE 1 0.0000
866 DISCOMFORT 3 0.0000
867 BLINDNESS 2 0.0000
868 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
869 POLLAKIURIA 2 0.0000
870 EATING DISORDER 1 0.0000
871 IMPAIRED WORK ABILITY 1 0.0000
872 HYPOACUSIS 2 0.0000
873 OVERDOSE 10 0.0000
874 PNEUMONIA 15 0.0000
875 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
876 CONDITION AGGRAVATED 14 0.0000
877 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
878 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
879 MUSCULOSKELETAL STIFFNESS 4 0.0000
880 NAUSEA 36 0.0000
881 GLOSSODYNIA 1 0.0000
882 HEART RATE IRREGULAR 1 0.0000
883 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
884 ABDOMINAL PAIN UPPER 9 0.0000
885 INJECTION SITE REACTION 3 0.0000
886 ADVERSE EVENT 4 0.0000
887 HYPOKALAEMIA 2 0.0000
888 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
889 RENAL DISORDER 2 0.0000
890 DISEASE RECURRENCE 2 0.0000
891 GAIT DISTURBANCE 8 0.0000
892 HEPATIC CANCER 1 0.0000
893 MYALGIA 7 0.0000
894 RESPIRATORY FAILURE 3 0.0000
895 LUNG DISORDER 2 0.0000
896 VISUAL IMPAIRMENT 5 0.0000
897 EPISTAXIS 3 0.0000
898 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
899 HAEMATEMESIS 1 0.0000
900 DIABETES MELLITUS 3 0.0000
901 ABDOMINAL DISTENSION 4 0.0000
902 VOMITING 18 0.0000
903 ECZEMA 2 0.0000
904 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
905 ARTHRITIS 3 0.0000
906 GASTRITIS 1 0.0000
907 BRADYCARDIA 2 0.0000
908 INJECTION SITE HAEMORRHAGE 3 0.0000
909 RASH PRURITIC 2 0.0000
910 OEDEMA 2 0.0000
911 RASH 16 0.0000
912 INFLUENZA LIKE ILLNESS 3 0.0000
913 MEMORY IMPAIRMENT 5 0.0000
914 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
915 URTICARIA 6 0.0000
916 DEMENTIA 1 0.0000
917 THROMBOCYTOPENIA 4 0.0000
918 SKIN EXFOLIATION 3 0.0000
919 URINARY TRACT INFECTION 6 0.0000
920 INCORRECT DOSE ADMINISTERED 8 0.0000
921 EYE IRRITATION 2 0.0000
922 BALANCE DISORDER 3 0.0000
923 PRODUCT STORAGE ERROR 3 0.0000
924 DYSSTASIA 1 0.0000
925 BONE PAIN 2 0.0000
926 BLADDER CANCER 2 0.0000
927 HEPATIC FAILURE 1 0.0000
928 THERAPEUTIC RESPONSE DECREASED 2 0.0000
929 STOMATITIS 2 0.0000
930 MUSCLE SPASMS 6 0.0000
931 ACUTE KIDNEY INJURY 5 0.0000
932 DIARRHOEA 21 0.0000
933 FEMUR FRACTURE 1 0.0000
934 BONE DENSITY DECREASED 1 0.0000
935 BLOOD GLUCOSE INCREASED 6 0.0000
936 HYPOTHYROIDISM 1 0.0000
937 CONFUSIONAL STATE 5 0.0000
938 RENAL FAILURE 4 0.0000
939 FALL 10 0.0000
940 FUNGAL INFECTION 1 0.0000
941 DEHYDRATION 4 0.0000
942 INJECTION SITE PRURITUS 2 0.0000
943 DEATH 25 0.0000
944 HYPERKALAEMIA 1 0.0000
945 SKIN BURNING SENSATION 2 0.0000
946 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
947 INFLUENZA 3 0.0000
948 DYSARTHRIA 1 0.0000
949 RHEUMATOID ARTHRITIS 3 0.0000
950 ANAEMIA 5 0.0000
951 DISORIENTATION 1 0.0000
952 INJECTION SITE BRUISING 2 0.0000
953 CARDIAC FAILURE CONGESTIVE 2 0.0000
954 DRY MOUTH 2 0.0000
955 DYSKINESIA 1 0.0000
956 DRUG DOSE OMISSION 4 0.0000
957 DEVICE LEAKAGE 1 0.0000
958 CONSTIPATION 5 0.0000
959 ANGIOEDEMA 1 0.0000
960 COGNITIVE DISORDER 1 0.0000
961 COMA 1 0.0000
962 BLOOD GLUCOSE DECREASED 1 0.0000
963 DRUG INTOLERANCE 2 0.0000
964 HAEMOGLOBIN DECREASED 2 0.0000
965 ILLNESS 2 0.0000
966 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
967 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
968 DEPENDENCE 1 0.0000
969 HYPONATRAEMIA 1 0.0000
970 FLATULENCE 1 0.0000
971 HERPES ZOSTER 1 0.0000
972 DECREASED APPETITE 4 0.0000
973 DISEASE PROGRESSION 2 0.0000
974 NASOPHARYNGITIS 3 0.0000
975 EXPOSURE DURING PREGNANCY 1 0.0000
976 AMNESIA 1 0.0000
977 FEBRILE NEUTROPENIA 1 0.0000
978 DRY SKIN 2 0.0000
979 HALLUCINATION 1 0.0000
980 DRUG DOSE OMISSION BY DEVICE 1 0.0000
981 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
982 COMPLETED SUICIDE 1 0.0000
983 TOXICITY TO VARIOUS AGENTS 2 0.0000
984 DEVICE ISSUE 1 0.0000
985 NO ADVERSE EVENT 2 0.0000
986 BREAST CANCER 1 0.0000
987 HAEMORRHAGE 1 0.0000
988 DRUG DEPENDENCE 1 0.0000